The X-Stop® Spacer for the symptons of lumbar spninal stenosis
Text size
Normal text size Larger text size Largest text size

Payment authorization process

The X-STOP procedure is covered by Medicare and select private health plans. Private health plans typically require you or your physician to submit paperwork for prior authorization or predetermination (approval) for coverage of an elective surgery.

Prior authorization is a process used by health plans to review certain medical and surgical health services. The goal is to ensure that the service is medically necessary.

Predetermination is a review process conducted by the health plan to verify the medical necessity of a planned procedure. Predetermination is often a condition of plan payment.

It’s important to follow the individual plan process outlined in the provider manual because the prior authorization and appeals processes vary from plan to plan.

If needed, your surgeon can provide you with more information regarding the prior authorization process. A Medtronic Provider Relations Specialist is also available to support you and your surgeon. Please ask your surgeon about the support offered by the Medtronic Provider Relations Specialist during this process. Learn more.

For more information about reimbursement information, please visit our Reimbursement Resource Center.

Talk to your primary care doctor or a spine specialist about the X-STOP Spacer.

Preop/Postop Ready for hte x-stop spacer Reimbursement center

Printer Printer friendly Envelope E-mail to a friend Bookmark Bookmark

This treatment is prescribed by your doctor. It is not for everyone. Please talk with your doctor and see if it is right for you. Your doctor should discuss all potential benefits and risks with you. Although many patients benefit from the use of this treatment, approximately half of the patients who received the X-STOP device in the 2-year study experienced a degree of pain relief and ability to increase their activity levels that was sufficient to be considered a successful outcome at 2 years after surgery. This compares with the control group treated with non-surgical care that had a 6% successful outcome treatment success rate.15